NCT05275478 2026-04-15Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid TumorsTango Therapeutics, Inc.Phase 1/2 Terminated110 enrolled
NCT05879185 2026-04-13A Study of XmAb23104 in People With SarcomaMemorial Sloan Kettering Cancer CenterPhase 2 Terminated6 enrolled 9 charts
NCT03420963 2026-03-20Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid TumorsM.D. Anderson Cancer CenterPhase 1 Terminated12 enrolled